Document 8VO7Grp1apKVxgep9jE4DJ26a

From: Clegg, Patsy M SCC-CHSE-PC Sent: Thursday, August 12, 2004 3:06 PM To: Sullivan, Nancy E SCC-CBAR; Tholstrup, Susan C SCC-HSE; Schmid, John L SHLOIL-Legal; Clegg, Patsy M SCC-CHSE-PC Subject: Shanghai Health Study - Recap of Contract/Business sponsor discussion Thanks to everyone for your participation in our discussion on Aug 11 on the Shanghai Health Study. The decisions/action items that I captured are as follows: Decisions: Stacy Methvin will sign contract amendment. Harshad Topiwala will be the business sponsor. Actions: Nancy will brief Stacy and Harshad. Patsy will notify Nancy when contract amendment is ready for signature. Nancy will take contract to Stacy for signature. Patsy will set up conference call to brief Stacy, Bill, and Harshad. ~gan[s) Patsy Patsy Clegg Product Steward Shell Chemical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals SH ELL-MCCLU RG-068036 Shanghai Health Study A project in Shanghai to study the effects of benzene exposure on the blood Principle Investigators: Dr. Richard Irons, University of Colorado Dr. Otto Wong, Applied Health Sciences The $21MM study is being funded by the Benzene Health Research Consortium which includes BP, ChevronTexaco, ConocoPhillips, ExxonMobil, Shell Chemical Company LP A clinical research lab has been built, equipped, and staffed on the campus of the School of Medicine at Fudon University in Shanghai. The lab will be gifted to the university. 26 area Shanghai hospitals are referring hematopoietic (blood and blood forming organs) related diseases to the study To date, just over 100 AML (acute myelogenous leukemia) and NHL (non-Hodgkin's lymphoma) cases have been referred. An independent Scientific Review Panel and an Ethics Review Panel have reviewed protocols and study progress. Shell is currently chairing the Oversight and Budget committees. The study is expected to conclude in 2007/8. SH ELL-MCCLU RG-068037